ProQR Presents in vivo Proof of Concept Data for the Axiomer® RNA Editing Platform Technology Press release … vivo proof of concept data will be presented at upcoming Oligonucleotide Therapeutics Society (OTS) Meeting on … by Endogenous ADAR Enzymes” will be presented during the Oligonucleotide Therapeutics Society (OTS) Meeting to be held … September 21, 2017
ProQR Announces Results for the Fourth Quarter and Full Year 2016 and Provides a Business Update Press release Key updates February 28, 2017
ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-010 for Cystic Fibrosis at Two Upcoming Scientific Conferences Press release … October 8 – 10, 2015 and the 11 th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS) in Leiden, The … October 01, 2015
ProQR to Present at Scientific and Investor Conferences in September Press release LEIDEN, the Netherlands, Sept. 06, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. September 06, 2016
ProQR Announces Presentations at the OTS Annual Meeting Press release LEIDEN, the Netherlands, Sept. 24, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. September 24, 2018
ProQR Announces Financial Results for the Third Quarter of 2018 Press release … $104.1 million. Delivered two presentations at the Oligonucleotide Therapeutics Society (OTS) conference on … November 07, 2018
ProQR Announces Results for the Third Quarter of 2016 Press release LEIDEN, the Netherlands, Nov. 14, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. November 14, 2016
ProQR Announces Third Quarter 2025 Operating and Financial Results Press release … risk. In October, the Company presented at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting in … November 06, 2025